As of October 11th, Rubraca (Rucaparib) has been approved for NHS use by NICE in its final draft guidance (NICE, 2019). The drug, developed by the University of Newcastle, will benefit women with...
As the scientific understanding and awareness of the detrimental effects smoking tobacco has on the lungs has grown, it has concurrently led to an increase in cigarette substitutes in order to...
With an ever-growing societal attitude of equality and the push forward towards feminism, there is a desire for the development of a male contraception in order to have both individual and shared...
The central nervous system (CNS) compromises the brain and spinal cord and is the most complex system in the human body; consisting of an estimated 100 billion neurons, each connected to thousands...
Opioids are the most commonly prescribed medications to manage chronic pain. They work by lowering pain signals the body sends to the brain, they also alter how the brain would react to pain. Opioids...
Patient-based forecast models follow patient cohorts through a framework which is the forecasters best understanding of a markets dynamics at a given time. Each forecast tells a story through...
The Centers for Medicare & Medicaid Services (CMS) recorded $3.5 trillion in National Health Expenditures (NHE) in 2017 which accounts for 17.9% of the U.S. GDP, and projected the NHE to...
Abilify MyCite was approved in November 2017 by the FDA. The medication contains aripiprazole with an ingestible sensor that digitally tracks whether the patient has taken it. It aims to address...
Artificial intelligence (AI) refers to intelligence demonstrated by technology rather than human intelligence. It is used in many platforms ranging from business sectors to educational...
